Nxera Pharma Co., Ltd. - Price Earnings Ratio

Nxera Pharma Co., Ltd.'s Fiscal Year is From January To December.

The item "Price-Earnings-Ratio" stands at -14.06 as of 09/30/2025, the highest value since 09/30/2023.

As of the end of Nxera Pharma Co., Ltd.'s third quarter, the item "Price Earnings Ratio" stands at -14.06. This represents an increase of 43.72 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.24 compared to the value the year prior.
The Serie's long term average value is -62.49. It's latest available value, on 09/30/2025, is 48.43 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +584.57 .
The Serie's change from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -85.44 .